{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:45:12Z","timestamp":1784306712749,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bbi.2018.03.022","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T13:53:27Z","timestamp":1521467607000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?"],"prefix":"10.1016","volume":"70","author":[{"given":"Elfi","family":"Vergaelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Schiweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Van Steeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Counotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Veling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Swillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmo","family":"Drexhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2018.03.022_b0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-3223(94)91163-0","article-title":"T-cell subsets in acute psychotic schizophrenic patients","volume":"35","author":"Achiron","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0010","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.biopsych.2012.11.006","article-title":"Immune system dysregulation in first-onset postpartum psychosis","volume":"73","author":"Bergink","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbi.2018.03.022_b0025","first-page":"1","article-title":"Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications","author":"Debnath","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2018.03.022_b0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2014.01.001","article-title":"Activation of Th17 cells in drug na\u00efve, first episode schizophrenia","volume":"51","author":"Ding","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0035","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1017\/S1461145710001653","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"14","author":"Drexhage","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2018.03.022_b0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","article-title":"Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia","volume":"73","author":"Fineberg","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02900219","article-title":"Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission","volume":"247","author":"Frommberger","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2018.03.022_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00018-011-0842-z","article-title":"Immunological aspects of 22q11.2 deletion syndrome","volume":"69","author":"Gennery","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"229\u2013240","key":"10.1016\/j.bbi.2018.03.022_b0055","first-page":"e3","article-title":"Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions","volume":"138","author":"Giacomelli","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0060","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/eji.200939305","article-title":"IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo","volume":"39","author":"Gy\u00fclv\u00e9szi","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0065","first-page":"835","article-title":"Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B","volume":"136","author":"Janssen","year":"1992","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.bbi.2018.03.022_b0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.118534","article-title":"Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"139","author":"Jawad","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbi.2018.03.022_b0075","doi-asserted-by":"crossref","first-page":"e66282","DOI":"10.1371\/journal.pone.0066282","article-title":"DGCR8-mediated production of canonical microRNAs is critical for regulatory T cell function and stability","volume":"8","author":"Jeker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2018.03.022_b0080","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/85845","article-title":"DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1","volume":"27","author":"Jerome","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbi.2018.03.022_b0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2249.2006.03038.x","article-title":"Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome","volume":"144","author":"Kanaya","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0090","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2018.03.022_b0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0269881112467089","article-title":"A review of anti-inflammatory agents for symptoms of schizophrenia","volume":"27","author":"Keller","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbi.2018.03.022_b0100","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbi.2008.05.002","article-title":"Reducing post-traumatic anxiety by immunization","volume":"22","author":"Lewitus","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2018.03.022_b0105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neubiorev.2015.05.014","article-title":"Inflammation in schizophrenia: a question of balance","volume":"55","author":"Leza","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2018.03.022_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2249.2010.04152.x","article-title":"Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles","volume":"161","author":"Lima","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0115","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11207","article-title":"Elevated proinflammatory markers in 22q11.2 deletion syndrome are associated with psychosis and cognitive deficits","author":"Mekori-Domachevsky","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.03.004","article-title":"Participation of interleukin 17A in neuroimmune interactions","volume":"41","author":"Moynes","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2018.03.022_b0135","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","article-title":"High rates of schizophrenia in adults with velo-cardio-facial syndrome","volume":"56","author":"Murphy","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12688\/f1000research.4439.1","article-title":"Myelin-specific T helper 17 cells promote adult hippocampal neurogenesis through indirect mechanisms","volume":"3","author":"Niebling","year":"2014","journal-title":"F1000Research"},{"key":"10.1016\/j.bbi.2018.03.022_b0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2015.01.026","article-title":"Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis","volume":"164","author":"Noto","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.03.022_b0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/adc.2003.026880","article-title":"Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden","author":"Oskarsdottir","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bbi.2018.03.022_b0155","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.intimp.2005.10.004","article-title":"Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines","volume":"6","author":"Pae","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2018.03.022_b0160","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0165","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jmg.34.10.798","article-title":"Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study","volume":"34","author":"Ryan","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbi.2018.03.022_b0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","article-title":"Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome","volume":"171","author":"Schneider","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2018.03.022_b0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2011.03.030","article-title":"Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder","volume":"129","author":"Shapiro","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.03.022_b0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00406-010-0098-x","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","volume":"260","author":"Steiner","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2018.03.022_b0185","first-page":"1","article-title":"Childhood trauma, psychosis liability and social stress reactivity: a virtual reality study","volume":"49","author":"Veling","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2018.03.022_b0190","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.4049\/jimmunol.0801218","article-title":"CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis","volume":"182","author":"Wolf","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clim.2010.04.011","article-title":"Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"136","author":"Zemble","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbi.2018.03.022_b0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.schres.2016.06.031","article-title":"Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis","volume":"176","author":"Zeni-Graiff","year":"2016","journal-title":"Schizophr. Res."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:10Z","timestamp":1760169010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159118300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"alternative-id":["S0889159118300758"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2018.03.022","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2018.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}